Colin Hill to Speak at Convergence Forum 2024
We’re thrilled to announce our participation at the Convergence Forum on May 9-10, 2024. Colin Hill will be a featured panelist in an engaging session titled: “Where Will AI Make the Biggest Impact This Year..and in the Future? What Should Your Organization Be Doing?” alongside Anna Huyghues-Despointes, Chief Corporate Development and Strategy Officer at Owkin […]
Colin Hill to Speak at Align Summit 2024
Join us at this year’s Align Summit, where the spotlight shines on artificial intelligence and machine learning in drug discovery and development. Our CEO, Colin Hill, will discuss Aitia’s strategic initiatives and recent collaborations in the realm of AI-enabled drug discovery. Learn more about the event and our participation here.
Colin Hill to Speak on AI’s Impact at MIT Imagination in Action Summit
Delighted to share that Colin Hill will be taking the stage as a featured speaker at the upcoming Imagination in Action Summit at MIT #MITforge2024 on April 18th! Anticipate invaluable insights into AI’s transformative impact on Life Sciences & Health. Get ready for groundbreaking perspectives at the forefront of innovation. More information about this event […]
Colin Hill to Speak at Yale Healthcare Conference
Delighted to share that Colin Hill will be taking the stage as a featured panelist at the upcoming Yale Healthcare Conference, on April 12th, 2024. Colin’s panel discussion titled “Not-So-Secret Weapon to Better Care: Precision Medicine for All” will explore the transformative role of AI in reshaping the landscape of drug discovery and development towards […]
Join Aitia at AACR Annual Meeting
Join us at the AACR Annual Meeting in San Diego on April 5 – 10, 2024. This meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to […]
HDTC Poster | Prediction of HD-related clinical outcome progression and imaging markers using AI-based Digital Twins
Pahriya Ashrap, So-Youn Shin, Jeanne Latourelle
Meet Aitia at the AD/PD Summit
Join us at the AD/PD Summit in Lisbon, Portugal on March 5 – 9, 2024. This conference is exclusively focused on advancing innovative strategies in therapy, prevention, clinical trials and diagnostic markers, in order to focus on driving successful collaborations among academia and industry, and finally leading to the development of innovative therapies. Make sure […]
Unveiling the AI Dominance in Biopharma: STAT Post JPM Conference Insights
JPM conference has echoed discussions about AI across the biopharmaceutical landscape. Catch up on key insights shared in the latest STAT article titled: “At Health Care’s Biggest Investor Conference, AI’s High Hopes Collided with Skepticism.” Sanofi’s chief executive, Paul Hudson, revealed the widespread integration of AI within the company: “More than 11,000 people across the […]
Servier and Aitia Announce a New Collaboration Focused on Parkinson’s Disease
Aitia‘s Gemini Digital Twins will help identify subpopulations of patients who could respond favorably to Servier’s LRRK2 in development treatment Suresnes (France), 08 January 2024 – Servier, an independent international pharmaceutical group, and Aitia, the leader in the application of causal AI and Digital Twins, have strengthened today their partnership by signing a new contract […]
Servier Will Apply Aitia’s Gemini Digital Twins to Parkinson’s Drug
Spotlight on our joint effort with Servier, strengthening our partnership by entering a new collaboration focused on neuroscience. The aim of this cooperation is to leverage Aitia’s Gemini Digital Twins to identify patients most likely to respond positively to Servier’s Leucine-Rich-Repeat-Kinase 2 inhibitor (LRRK2i) in development treatment for Parkinson’s disease. Read the full article on […]